SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Arthur Radley who wrote (10693)7/8/1999 10:56:00 PM
From: Biomaven  Read Replies (1) | Respond to of 17367
 
TD,

I really doubt that there could be any serious partnership negotiations right now before the Neuprex results are analyzed and made public.

The conventional wisdom is that the optimum time for a biotech to partner a drug (if they can wait that long of course) is about when the NDA is filed.

Peter